Last update: October 16, 2020
Office-based addictions treatment (OBAT) is the use of medications in combination with navigator services to coordinate counseling and behavioral therapies to treat both substance use disorder (SUD) and opioid use disorder (OUD).
Care providers are registered with the Drug Enforcement Administration (DEA) to prescribe OUD treatment medication. Increasing primary care provider (PCP) participation in SUD treatment, particularly medication-assisted treatment (MAT), offers an opportunity to improve access and expand integration of care within NJ FamilyCare. The majority of NJ FamilyCare beneficiaries are covered by a Medicaid managed care organization (MCO) and receive their primary care through contracted provider practices. Until now, many PCPs have not participated in the treatment of substance use-related disorders (beyond referral) because of perceived barriers to providing treatment, a perceived lack of reimbursement and/or a lack of experience/knowledge treating these conditions.
These barriers include prior authorization requirements and discerning what is covered by the MCO and/or the state. NJ FamilyCare has designed the OBAT program to support care providers by:
For more information about the OBAT program, refer to the State of New Jersey Department of Human Services Division of Medical Assistance & Health Services Newsletter (Volume 29, No. 06, March 2019) by visiting njmmis.com > Recent Newsletters > Volume 29, No. 06 – Office-Based Addictions Treatment (OBAT) and Elimination of Prior Authorization for Medication-Assisted Treatment (MAT) for All MAT Providers, Effective Jan. 1, 2019.